ATP Citrate Lyase
ATP citrate lyase (ATP citrate synthase, ACLY) is a transferase that catalyzes the conversion of citrate and coenzyme A to acetyl-CoA. ACLY is the key regulator between the high rates of aerobic glycolysis and de novo lipid synthesis exhibited in many types of tumor cells.
Products for ATP Citrate Lyase
- Cat.No. Product Name Information/Activity
-
BCC4097
BMS-303141
BMS-303141 is a potent, cell-permeable ATP-citrate lyase (ACL) inhibitor with an IC50 of 0.13 μM.
-
BCC7956
MEDICA 16
87272-20-6
-
BCC6342
SB 204990
SB 204990 is a potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme.
